Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Shankar Musunuri
Recent news which mentions Shankar Musunuri
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
January 13, 2023
Tickers
INNO
Tags
Michael Christie
Medical Devices
Jeff Aronin
From
Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
June 21, 2022
Tags
Biotech
Coronavirus
Insurance
From
Business Journals
Ocugen to resume Covaxin trials 'immediately' after FDA lifts its latest clinical hold
May 23, 2022
Tags
Pharmaceuticals
Shankar Musunuri
Health Care
From
Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
April 18, 2022
Tags
Ocugen Inc/
Shankar Musunuri
Pharmaceuticals
From
Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022
Tickers
INNO
Tags
Venatorx Pharmaceuticals
Pharmaceuticals
Shankar Musunuri
From
Business Journals
FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets
February 18, 2022
Tags
Shankar Musunuri
Pharmaceuticals
Coronavirus
From
Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
January 27, 2022
Tags
Insurance
Health Care
Biotech
From
Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
November 05, 2021
Tags
Insurance
Health Care
Ocugen
From
Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
October 29, 2021
Tickers
INNO
Tags
OptiNose Inc/
Roundup
Pharmaceuticals
From
Business Journals
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.